Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06737913
What this trial is testing

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 76
Testing effectiveness (Phase 2)Study completedNCT04044313
What this trial is testing

HAIC Plus Lenvatinib and Toripalimab for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Shi Ming 36
Not applicableUnknownNCT06505486
What this trial is testing

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 21
Large-scale testing (Phase 3)UnknownNCT05866172
What this trial is testing

HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 264
Large-scale testing (Phase 3)UnknownNCT04667351
What this trial is testing

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 400
Testing effectiveness (Phase 2)UnknownNCT06285019
What this trial is testing

Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 65
Testing effectiveness (Phase 2)Study completedNCT02316028
What this trial is testing

Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)

Who this might be right for
Liver MetastasisColorectal Cancer
Universitair Ziekenhuis Brussel 11
Testing effectiveness (Phase 2)WithdrawnNCT03069950
What this trial is testing

Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

Who this might be right for
Colorectal Adenocarcinoma Metastatic to the Liver
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07557914
What this trial is testing

Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes

Who this might be right for
HCC - Hepatocellular CarcinomaDiabetes
Haibo Shao 32
Testing effectiveness (Phase 2)Study completedNCT06071052
What this trial is testing

TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens

Who this might be right for
Liver Metastasis Colon Cancer
First Affiliated Hospital, Sun Yat-Sen University 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07584018
What this trial is testing

The DoHAICs Study Expansion Phase

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT07646717
What this trial is testing

Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00587067
What this trial is testing

A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy

Who this might be right for
Hepatic Cancer
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)UnknownNCT04994236
What this trial is testing

Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy

Who this might be right for
Hepatocellular Carcinoma
Hui-Chuan Sun 49
Testing effectiveness (Phase 2)UnknownNCT05839197
What this trial is testing

A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC

Who this might be right for
Macrotrabecular Massive Hepatocellular Carcinoma
Wan-Guang Zhang 38
Testing effectiveness (Phase 2)UnknownNCT05166772
What this trial is testing

Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00200200
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

Who this might be right for
Hepatic MetastasesColon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 73
Testing effectiveness (Phase 2)Study completedNCT03493061
What this trial is testing

Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM

Who this might be right for
Colo-rectal CancerLiver Metastases
Sun Yat-sen University 60
Early research (Phase 1)Not Yet RecruitingNCT07183852
What this trial is testing

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 18
Large-scale testing (Phase 3)Ended earlyNCT00110123
What this trial is testing

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

Who this might be right for
Intraocular MelanomaMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Next Page